Rituximab in the treatment of non-Hodgkin's lymphoma – a critical evaluation of randomized controlled trials

By Griffin Morag Meriel   Morley Nick  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 803-811

Informa Healthcare

Access to resources Recommend Favorite

Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients

By Asfour Inas   Shazly Sherin   Fayek Manal   Hegab Hany   Raouf Soha   Moussa Mohamed  

Biological Trace Element Research, Vol. 110, Iss. 1, 2006-04 ,pp. : 19-32

Humana Press, Inc

Access to resources Recommend Favorite

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

By Gaikwad Nilesh W.   Yang Li   Weisenburger Dennis D.   Vose Julie   Beseler Cheryl   Rogan Eleanor G.   Cavalieri Ercole L.  

Biomarkers, Vol. 14, Iss. 7, 2009-11 ,pp. : 502-512

Informa Healthcare

Access to resources Recommend Favorite

The Impact of High-dose Sodium Selenite Therapy on Bcl-2 Expression in Adult Non-Hodgkin's Lymphoma Patients: Correlation with Response and Survival

By  

Biological Trace Element Research, Vol. 120, Iss. 1-3, 2007-12 ,pp. : 1-10

Humana Press, Inc

Access to resources Recommend Favorite

BiovaxID™: a personalized therapeutic cancer vaccine for non-Hodgkin’s lymphoma

By Lee Seung-Tae   Jiang Yun-Fang   Park Keon-Uk   Woo Alison F   Neelapu Sattva S  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 113-122

Informa Healthcare

Access to resources Recommend Favorite